Insights

Guess which 2 ASX All Ordinaries shares smashed 52-week highs amid today’s carnage

Here’s what drove these shares to outperform on Tuesday.
The post Guess which 2 ASX All Ordinaries shares smashed 52-week highs amid today’s carnage appeared first on The Motley Fool Australia. –

Tuesday was a rough day on the market, with the All Ordinaries Index (ASX: XAO) closing 0.99% lower.

That’s better than its intraday performance. At its lowest point of the day, the index was sporting a 2.5% tumble.

But two All Ords shares stood out among the pack, managing to dodge most of the carnage to record new 52- week highs? Let’s take a look.

2 ASX All Ordinaries shares hitting new 52-week highs

Amcor Plc (ASX: AMC)

The Amcor share price hit an all-time high of $18.26 on Tuesday despite the All Ordinaries’ woes. Interestingly, the company met its new record without releasing any news to the market.

Amcor produces packaging solutions for products like food, beverages, and pharmaceuticals. It operates in more than 40 countries and is listed on both the ASX and the New York Stock Exchange.

The last time the market heard from the company was last week when it released its results for the quarter ended 31 March.

Over the period, Amcor brought in US$3.7 billion of sales – a US$500 million increase on those of the prior comparable quarter.

That likely helped it make a gross profit of US$731 million – a 7% increase.

The Amcor share price has gained 10% since the start of 2022, outperforming the All Ordinaries Index by nearly 18% year to date.

Regis Healthcare Ltd (ASX: REG)

The Regis Healthcare share price leapt 2.5% to a new 52-week high of $2.34 before tumbling to join the All Ordinaries Index in the red today.

The residential care home operator hasn’t released any news to the ASX this month. Still, the market has been bidding its share price higher. It’s gained 5% since the end of April.

The last time the ASX heard from Regis Healthcare was on 14 April. Then, the company announced it had settled a legal dispute brought against its subsidiary, Regis Aged Care by Oneview Healthcare (ASX: ONE).

Oneview Healthcare previously alleged Regis Healthcare breached a collaboration agreement.

The case was settled without either party admitting liability.

The Regis Healthcare share price has gained nearly 19% since the start of 2022. By doing so, it has beaten the All Ordinaries Index’s 2022 performance by 25%.

The post Guess which 2 ASX All Ordinaries shares smashed 52-week highs amid today’s carnage appeared first on The Motley Fool Australia.

Should you invest $1,000 in Amcor right now?

Before you consider Amcor, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Amcor wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Macquarie picks ASX 200 shares to buy in this volatile environment
These were the best performers on the ASX 200 last week
Guess which ASX 200 shares are defying today’s sell-off to climb higher
3 ASX 300 shares rocking new 52-week highs on Thursday
Why Alliance Aviation, Amcor, Core Lithium, and QBE shares are storming higher

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Amcor Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!